Backboards: 
Posts: 159

from b2, where I left a message and link for some backup, the ucsf paxlovid study results are about long covid. paxlovid is still useful, and

the earlier the better. the article includes mention of that.

it’s weird though with the throwaway inclusion about rebound. like ok, it can happen; but most of us will/should take risk of that vs. overall help. there was another article last week about experts trying to figure out why so few people aren’t taking advantage of it. misrepresenting results won’t help with that.



Post a message   top
Replies are disabled on threads older than 7 days.